The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy
Global and Regional Health Technology Assessment · 12.03.2026 · 13 (1) · 58-67
DOI: 10.33393/grhta.2026.3703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global and Regional Health Technology Assessment, online erschienen am 12.03.2026. Verfasst von Chiara Bini und 4 weiteren Autor:innen. Beteiligte Einrichtung: CEIS-EEHTA, Faculty of Economics, University of Rome "Tor Vergata", Rome - Italy. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Chronic spontaneous urticaria (CSU) is a debilitating dermatological disease. The study aimed toestimate the indirect costs and out-of-pocket expenses incurred by CSU patients in Italy.
Methods
The economic model was based on data collected through a survey conducted among patients andcaregivers with the support of the Association for the Research and Cure of Urticaria (ARCO). Disease severitywas classified into three categories: mild, moderate and severe. Indirect costs were estimated using the humancapital approach. Out-of-pocket expenses were estimated in terms of direct healthcare costs borne by the patientand direct non-healthcare costs.
Results
Data were analyzed for 122 patients; 7% of these reported mild CSU, 16% moderate and 78% severe. Theaverage age was 46.8 years, with an average age at diagnosis of 38.2 years. Overall, 50% of employed patientslost workdays due to CSU, and 63.3% reported reduced productivity at work; 45.1% of patients received caregiversupport, with 37.9% of employed caregivers reporting workdays lost. The economic model estimated an averageannual indirect cost per patient with CSU of €4,281, mainly due to presenteeism (59%). Indirect costs increasewith the severity of the disease. Average annual out-of-pocket expenses was €502.7 per patient.
Conclusions
The study conducted based on data directly reported by patients could contribute to a better understanding of CSU, thereby promoting a more efficient approach to the care and support of patients and theirfamilies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CEIS-EEHTA, Faculty of Economics, University of Rome "Tor Vergata", Rome - Italy.
- Department of Pharmaceutical Sciences - DISFARM, University of Milan, Milan - Italy.
- Novartis Farma S.p.A., Milan - Italy.
- Association for the Research and Cure of Urticaria (ARCO), Milan - Italy.
Zitieren
APA
Bini, C., Marcellusi, A., Scansetti, V., Casoli, L., & Radaelli, E. (2026). The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy. Global and Regional Health Technology Assessment, 13(1), 58-67. https://doi.org/10.33393/grhta.2026.3703
Vancouver
Bini C, Marcellusi A, Scansetti V, Casoli L, Radaelli E. The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy. Global and Regional Health Technology Assessment. 2026;13(1):58-67. doi:10.33393/grhta.2026.3703
BibTeX
@article{Bini2026,
author = {Bini, Chiara and Marcellusi, Andrea and Scansetti, Virginia and Casoli, Lucia and Radaelli, Elena},
title = {The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy},
journal = {Global and Regional Health Technology Assessment},
year = {2026},
volume = {13},
number = {1},
pages = {58--67},
doi = {10.33393/grhta.2026.3703}
}
EUVIMED